1. Home
  2. TXG vs ARI Comparison

TXG vs ARI Comparison

Compare TXG & ARI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • ARI
  • Stock Information
  • Founded
  • TXG 2012
  • ARI 2009
  • Country
  • TXG United States
  • ARI United States
  • Employees
  • TXG N/A
  • ARI N/A
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • ARI Real Estate Investment Trusts
  • Sector
  • TXG Industrials
  • ARI Real Estate
  • Exchange
  • TXG Nasdaq
  • ARI Nasdaq
  • Market Cap
  • TXG 1.7B
  • ARI 1.5B
  • IPO Year
  • TXG 2019
  • ARI 2009
  • Fundamental
  • Price
  • TXG $13.96
  • ARI $10.98
  • Analyst Decision
  • TXG Buy
  • ARI Hold
  • Analyst Count
  • TXG 11
  • ARI 4
  • Target Price
  • TXG $13.41
  • ARI $10.08
  • AVG Volume (30 Days)
  • TXG 2.8M
  • ARI 704.0K
  • Earning Date
  • TXG 10-28-2025
  • ARI 10-29-2025
  • Dividend Yield
  • TXG N/A
  • ARI 9.18%
  • EPS Growth
  • TXG N/A
  • ARI N/A
  • EPS
  • TXG N/A
  • ARI N/A
  • Revenue
  • TXG $644,466,000.00
  • ARI $273,783,000.00
  • Revenue This Year
  • TXG $1.75
  • ARI $26.08
  • Revenue Next Year
  • TXG N/A
  • ARI $18.31
  • P/E Ratio
  • TXG N/A
  • ARI N/A
  • Revenue Growth
  • TXG 2.02
  • ARI 55.89
  • 52 Week Low
  • TXG $6.78
  • ARI $7.70
  • 52 Week High
  • TXG $24.38
  • ARI $11.04
  • Technical
  • Relative Strength Index (RSI)
  • TXG 56.43
  • ARI 73.49
  • Support Level
  • TXG $12.97
  • ARI $10.42
  • Resistance Level
  • TXG $14.57
  • ARI $10.61
  • Average True Range (ATR)
  • TXG 0.55
  • ARI 0.16
  • MACD
  • TXG -0.05
  • ARI 0.07
  • Stochastic Oscillator
  • TXG 62.80
  • ARI 93.69

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

Share on Social Networks: